Cadrenal Therapeutics (CVKD) vs XORTX Therapeutics (XRTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cadrenal Therapeutics is the larger company by market cap ($3.3 million vs $3.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CVKD | XRTX |
|---|---|---|
| Share price | $0.9133 | $1.78 |
| Market cap | $3.26M | $3.23M |
| 1-day change | -6.07% | +2.01% |
| Forward P/E | — | 2.22 |
| EPS (TTM) | $-4.91 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.50 | $7.05 |
| 52-week low | $0.85 | $1.59 |
| Distance from 52-week high | -93.70% | -74.75% |
| Average volume | 454.72K | 225.78K |
| Shares outstanding | 3.57M | 1.82M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CVKD vs XRTX FAQ
Which is bigger, Cadrenal Therapeutics or XORTX Therapeutics?
Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $3.26M compared with $3.23M for XORTX Therapeutics (XRTX).
Are Cadrenal Therapeutics and XORTX Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.